AD risk loci are significantly enriched in microglial enhancer regions (e.g., binding pockets of SPI1, ELF2, and RUNX1), with late-stage AD exhibiting epigenomic erosion that leads to loss of cellular identity [247]. Here, ELF2 is linked to Alzheimer disease.